CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 140 enrolled
Drug / intervention
Venlafaxine +1 moredrug
Likely dose
Venlafaxine 375 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00602537
NCT00602537Phase 4Completed
CompareCT.gov

Treatment of Bipolar Type II Major Depression

University of Pennsylvania·interventional·Posted Jan 28, 2008·Updated Apr 25, 2017

In Brief

A Phase 4 clinical trial evaluating Venlafaxine and Lithium Carbonate for Bipolar Disorder and Depression. Completed, enrolled 140 participants across 1 site.

Detailed Summary

This study will compare the safety and effectiveness of antidepressant therapy versus mood stabilizing therapy in treating people with bipolar type II major depression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder, Depression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 28, 2008
Enrollment StartDec 1, 2007
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 18.4 years ago

Interventions

Venlafaxinedrug

75 to 375 mg

Lithium Carbonatedrug

300 to 2400 mg